← Open Payments lookup

ENRIQUE LIRAG: Open Payments

NPI 1932200219 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,787 in 132 payments from 12 companies in 2025. Trend: 2023 $1,566 · 2024 $2,205 · 2025 $2,787

Food & beverage: $2,787
CompanyPaymentsAmount
Alkermes, Inc.21$563
E.R. Squibb & Sons, L.L.C.21$462
ABBVIE INC.17$340
Vanda Pharmaceuticals Inc.11$250
Teva Pharmaceuticals USA, Inc.13$249
Janssen Pharmaceuticals, Inc14$243
Lundbeck LLC11$218
Neurocrine BioSciences, Inc.8$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$126
Otsuka America Pharmaceutical, Inc.4$85

Products named: COBENFY, ARISTADA, VRAYLAR, REXULTI, FANAPT, INVEGA SUSTENNA, INGREZZA, AUSTEDO XR.

Industry payments across PA — which companies pay providers there.